3
Total investments
2
Early stage
0
Mid stage
0
Late stage
10y
Years active
Portfolio
3 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
2022
๐งฌ Cutting-edge learning experience to address Life Sciences future challenges ๐ฆ
Our interactive digital lab allows anyone to master laboratory procedures without physical equipment. We can simulate protocols of any difficulty, making Aubaree Lab suitable for both young talents and working professionals.
๐ฉโ๐ Suitable for any school or university program ๐งโ๐ฌ
Aubaree Lab enhances the learning experience and improves learning outcomes. Our simulations are designed using gamification techniques to capture learners attention. We believe in a learning-by-doing approach and provide a tool for endless repetition and practice.
๐งช Interactive digital twin for Biotech, Pharma, and service companies ๐งซ
We also provide companies with simulators of their unique laboratories, including laboratory workflow, protocols, lab equipment and SOPs. Aubaree Lab enables fast and easy onboarding, saving money and time, reducing human errors, increasing employee performance, and optimizing the entire product cycle.
Investor
2022
Eligens.io is a pioneering digital health company transforming preventive healthcare globally. Our cutting-edge approach merges data-driven insights with tailored health strategies, targeting serious disease prevention. Were active in over 70 countries, with a special focus on regions like Latin America, Central Asia, and Europe.
Our digital health platform is our cornerstone, engaging customers with a unique, recurring revenue model. Key offerings include:
-- DNA Ancestry Testing: A viral product promoting social media engagement and organic growth through shared ancestral discoveries.
-- Genetic Health Risk Analysis: Utilizing DNA data to pinpoint individual health risks and the need for personalized prevention.
-- Personalized Prevention Plans: Customized plans involving blood tests, consultations, and medication, based on genetic analysis and in alignment with clinical guidelines.
Our platform employs AI and machine learning for DNA test analysis, questionnaires, and medical data processing, to continuously evaluate disease risks and suggest prevention and treatment strategies. This innovative method not only provides actionable insights for customers but also aids drug development and research.
Experiencing rapid customer growth, Eligens validates the success of its business model. The team, led by Founder and CEO Valery Ilinsky, a biochemistry expert, is committed to delivering groundbreaking health solutions.
Eligens, headquartered in Latvia, operates divisions in Brazil, Armenia, and Hong Kong. More than a healthcare company, we are a tech-driven enterprise empowering individuals to manage their health proactively. Join us in our quest to redefine preventive healthcare, making it more accessible and effective across the globe.
Experience ยท 5 entries
All (5)
Investments (3)
Founder (2)
2022
Investor
2022
๐งฌ Cutting-edge learning experience to address Life Sciences future challenges ๐ฆ
Our interactive digital lab allows anyone to master laboratory procedures without physical equipment. We can simulate protocols of any difficulty, making Aubaree Lab suitable for both young talents and working professionals.
๐ฉโ๐ Suitable for any school or university program ๐งโ๐ฌ
Aubaree Lab enhances the learning experience and improves learning outcomes. Our simulations are designed using gamification techniques to capture learners attention. We believe in a learning-by-doing approach and provide a tool for endless repetition and practice.
๐งช Interactive digital twin for Biotech, Pharma, and service companies ๐งซ
We also provide companies with simulators of their unique laboratories, including laboratory workflow, protocols, lab equipment and SOPs. Aubaree Lab enables fast and easy onboarding, saving money and time, reducing human errors, increasing employee performance, and optimizing the entire product cycle.
Investor
2022
Eligens.io is a pioneering digital health company transforming preventive healthcare globally. Our cutting-edge approach merges data-driven insights with tailored health strategies, targeting serious disease prevention. Were active in over 70 countries, with a special focus on regions like Latin America, Central Asia, and Europe.
Our digital health platform is our cornerstone, engaging customers with a unique, recurring revenue model. Key offerings include:
-- DNA Ancestry Testing: A viral product promoting social media engagement and organic growth through shared ancestral discoveries.
-- Genetic Health Risk Analysis: Utilizing DNA data to pinpoint individual health risks and the need for personalized prevention.
-- Personalized Prevention Plans: Customized plans involving blood tests, consultations, and medication, based on genetic analysis and in alignment with clinical guidelines.
Our platform employs AI and machine learning for DNA test analysis, questionnaires, and medical data processing, to continuously evaluate disease risks and suggest prevention and treatment strategies. This innovative method not only provides actionable insights for customers but also aids drug development and research.
Experiencing rapid customer growth, Eligens validates the success of its business model. The team, led by Founder and CEO Valery Ilinsky, a biochemistry expert, is committed to delivering groundbreaking health solutions.
Eligens, headquartered in Latvia, operates divisions in Brazil, Armenia, and Hong Kong. More than a healthcare company, we are a tech-driven enterprise empowering individuals to manage their health proactively. Join us in our quest to redefine preventive healthcare, making it more accessible and effective across the globe.
2019
Co-Founder
2019
Intent.ai is a privacy-respectful programmatic ad platform that offers highly precise targeting options. With our patented AI technology, executing ad campaigns becomes easy and fast, providing businesses with a powerful tool for competitive performance marketing. Intent.ai was founded in the United States in 2018 and currently operates in the US, Armenia, Nigeria, and Tunisia ๐๐ผ
2016
2015
Founder / CEO
2015
We partner with successful people and corporations to nurture innovative businesses from idea to exit, providing investment, incubation, resources, access to industry and technical assistance. Our main focus is the technology fuelling a more personalized approach to healthcare, education and communication. The portfolio includes genetic testing company Genotek, children development counseling platform Profilum, corporate communications tool Tada Team and others.
Investment activity
2016โ2022 ยท 3 investments
Recent (last 2 years)Earlier
Similar investors
Investors in Armenia




